Abstract
A novel vector with high gene delivery efficiency and special cell targeting ability was developed using a good strategy that utilized low molecular weight polyethylenimine (PEI; molecular weight, 600 KDa [PEI600]) cross-linked to β-cyclodextrin (β-CyD) via a facile synthetic route. Human epidermal growth factor receptor 2 (Her-2) are highly expressed in a variety of human cancer cells and are potential targets for cancer therapy. MC8 peptides, which have been proven to combine especially with Her-2 on cell membranes were coupled to PEI-β-CyD using N-succinimidyl-3-(2-pyridyldithio) propionate as a linker. The ratios of PEI600, β-CyD, and peptide were calculated based on proton integral values obtained from the 1H-NMR spectra of the resulting products. Electron microscope observations showed that MC8-PEI-β-CyD can efficiently condense plasmid DNA (pDNA) into nanoparticles of about 200 nm, and MTT assays suggested the decreased toxicity of the polymer. Experiments on gene delivery efficiency in vitro showed that MC8-PEI-β-CyD/pDNA polyplexes had significantly greater transgene activities than PEI-β-CyD/pDNA in the Skov3 and A549 cells, which positively expressed Her-2, whereas, no such effect was observed in the MCF-7 cells, which negatively expressed Her-2. Our current research indicated that the synthesized nonviral vector shows improved gene delivery efficiency and targeting specificity in Her-2 positive cells.
Similar content being viewed by others
References
Li, D., Yu, H., Huang, H., Shen, F., Wu, X., Li, J., et al. (2007). FGF receptor-mediated gene delivery using ligands coupled to polyethylenimine. Journal of Biomaterials Applications, 22, 163–180.
Morille, M., Passirani, C., Vonarbourg, A., Clavreul, A., & Benoit, J. P. (2008). Progress in developing cationic vectors for non-viral systemic gene therapy against cancer. Biomaterials, 29, 3477–3496.
Pack, D. W., Hoffman, A. S., Pun, S., & Stayton, P. S. (2005). Design and development of polymers for gene delivery. Nature Reviews, 4, 581–593.
Lee, M., & Kim, S. W. (2005). Polyethylene glycol-conjugated copolymers for plasmid DNA delivery. Pharmaceutical Research, 22, 1–10.
Demeneix, B., Behr, J., Boussif, O., Zanta, M. A., Abdallah, B., & Remy, J. (1998). Gene transfer with lipospermines and polyethylenimines. Advanced Drug Delivery Reviews, 30, 85–95.
Goyal, R., Tripathi, S. K., Tyagi, S., Ravi, R. K., Ansari, K. M., Shukla, Y., et al. (2011). Gellan gum blended PEI nanocomposites as gene delivery agents: evidences from in vitro and in vivo studies. European Journal of Pharmaleutics and Biopharmaceutics, 79, 3–14.
Swami, A., Kurupati, R. K., Pathak, A., Singh, Y., Kumar, P., & Gupta, K. C. (2007). A unique and highly efficient non-viral DNA/siRNA delivery system based on PEI-bisepoxide nanoparticles. Biochemical and Biophysical Research Communications, 362, 835–841.
Remant Bahadur, K. C., & Uludağ, H. (2011). A comparative evaluation of disulfide-linked and hydrophobically-modified PEI for plasmid delivery. Journal of Biomaterials Science, 22, 873–892.
Chumakova, O. V., Liopo, A. V., Andreev, V. G., Cicenaite, I., Evers, B. M., Chakrabarty, S., et al. (2008). Composition of PLGA and PEI/DNA nanoparticles improves ultrasound-mediated gene delivery in solid tumors in vivo. Cancer Letters, 261, 215–225.
Wada, K., Arima, H., Tsutsumi, T., Chihara, Y., Hattori, K., Hirayama, F., et al. (2005). Improvement of gene delivery mediated by mannosylated dendrimer/alpha-cyclodextrin conjugates. Journal Control Release, 104, 397–413.
Tang, G. P., Guo, H. Y., Alexis, F., Wang, X., Zeng, S., Lim, T. M., et al. (2006). Low molecular weight polyethylenimines linked by beta-cyclodextrin for gene transfer into the nervous system. The Journal of Gene Medicine, 8, 736–744.
Chertok, B., David, A. E., & Yang, V. C. (2011). Polyethyleneimine-modified iron oxide nanoparticles for brain tumor drug delivery using magnetic targeting and intra-carotid administration. Biomaterias, 31, 6317–6324.
Youn, J. I., Park, S. H., Jin, H. T., Lee, C. G., Seo, S. H., Song, M. Y., et al. (2008). Enhanced delivery efficiency of recombinant adenovirus into tumor and mesenchymal stem cells by a novel PTD. Cancer Gene Therapy, 15, 703–712.
Rao, K. S., Reddy, M. K., Horning, J. L., & Labhasetwar, V. (2008). TAT-conjugated nanoparticles for the CNS delivery of anti-HIV drugs. Biomaterials, 29, 4429–4438.
Schmidt, N., Mishra, A., Lai, G. H., & Wong, G. C. (2010). Arginine-rich cell-penetrating peptides. FEBS Letters, 584, 1806–183.
Li, Z., Zhao, R., Wu, X., Sun, Y., Yao, M., Li, J., et al. (2005). Identification and characterization of a novel peptide ligand of epidermal growth factor receptor for targeted delivery of therapeutics. The FASEB Journal, 19, 1978–1985.
Mendonça, L. S., Firmino, F., Moreira, J. N., Pedrosode Lima, M. C., & Simões, S. (2010). Transferrin receptor-targeted liposomes encapsulating anti-BCR-ABL siRNA or as ODN for chronic myeloid leukemia treatment. Bioconjug Chemistry, 21, 157–168.
Neu, M., Fischer, D., & Kissel, T. (2005). Recent advances in rational gene transfer vector design based on poly(ethylene imine) and its derivatives. The Journal of Gene Medicine, 7, 992–1009.
Fortune, J. A., Novobrantseva, T. I., & Klibanov, A. M. (2011). Highly effective gene transfection in vivo by alkylated polyethylenimine. Journal of Drug Delivery, 20, 40–58.
Houimel, M., Schneider, P., Terskikh, A., & Mach, J. P. (2001). Selection of peptides and synthesis of pentameric peptabody molecules reacting specifically with ErbB-2 receptor. International Journal of Cancer, 92, 748–755.
Boussif, O., Lezoualc'h, F., Zanta, M. A., Mergny, M. D., Scherman, D., Demeneix, B., et al. (1995). A versatile vector for gene and oligonucleotide transfer into cells in culture and in vivo: polyethylenimine. Proceedings of the National Academy of Sciences of the United States of America, 92, 7297–7301.
Liu, G., Xie, J., Zhang, F., Wang, Z., Luo, K., Zhu, L., et al. (2011). N-Alkyl-PEI-functionalized iron oxide nanoclusters for efficient siRNA delivery. Small (Weinheim an der Bergstrasse, Germany), 7, 2742–2749.
Bai, X., Miao, D., Li, J., Goltzman, D., & Karaplis, A. C. (2004). Transgenic mice overexpressing human fibroblast growth factor 23 (R176Q) delineate a putative role for parathyroid hormone in renal phosphate wasting disorders. Endocrinology, 145, 5269–5279.
Cai, L., Qiu, N., Li, X., Luo, K., Chen, X., Yang, L., et al. (2011). A novel truncated basic fibroblast growth factor fragment-conjugated poly (ethylene glycol)-cholesterol amphiphilic polymeric drug delivery system for targeting to the FGFR-overexpressing tumor cells. International Journal of Pharmaceutics, 408, 173–182.
Slamon, D. J., Godolphin, W., Jones, L. A., Holt, J. A., Wong, S. G., Keith, D. E., et al. (1989). Studies of the HER-2/Neu proto-oncogene in human breast and ovarian cancer. Science, 244, 707–712.
Liang, B., He, M. L., Xiao, Z. P., Li, Y., Chan, C. Y., Kung, H. F., et al. (2008). Synthesis and characterization of folate-PEG-grafted-hyperbranched-PEI for tumor-targeted gene delivery. Biochemical and Biophysical Research Communications, 367, 874–880.
Statement
We declare that there is no conflict of interest in this paper.
Author information
Authors and Affiliations
Corresponding author
Additional information
Wei Deng and Hefang Xiao contributed equally as first authors.
Rights and permissions
About this article
Cite this article
Deng, W., Xiao, H., Zeng, X. et al. MC8 Peptide-Mediated Her-2 Receptor Targeting Based on PEI-β-CyD as Gene Delivery Vector. Appl Biochem Biotechnol 169, 450–461 (2013). https://doi.org/10.1007/s12010-012-9959-2
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12010-012-9959-2